...
search icon
tlph-img

Talphera Inc. Share Price

TLPH
NAQ
$0.797
-$0.02
(-2.46%)
1D
Industry: Pharmaceuticals Sector: Health Care

Talphera Inc. Analyst Forecast

Talphera Inc. Share Price Chart

Talphera Inc. Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$37.86M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
59.90K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.47
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.38 L
$1.57 H
$0.797

About Talphera Inc., Common Stock

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis, as well as Fedsyra and phenylephrine ready-to-use pre-filled syringe product candidates. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is based in San Mateo, California. more

Industry: PharmaceuticalsSector: Health Care

Talphera Inc. Stock Returns

Time FrameTLPHSectorS&P500
1-Week Return2.97%0.75%0.54%
1-Month Return-21.14%-0.88%-2.01%
3-Month Return-37.03%2.08%-0.28%
6-Month Return93.4%18.91%6.04%
1-Year Return33.16%6.98%12.92%
3-Year Return-51.65%16.78%65.15%
5-Year Return-98.38%33.02%73.52%
10-Year Return-98.84%142.35%266.07%

Talphera Inc. Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue5.42M378.00K1.77M651.00K-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":6.98,"profit":true},{"date":"2022-12-31","value":32.7,"profit":true},{"date":"2023-12-31","value":12.02,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue6.03M3.01M1.65M5.55M6.72M[{"date":"2020-12-31","value":89.79,"profit":true},{"date":"2021-12-31","value":44.75,"profit":true},{"date":"2022-12-31","value":24.52,"profit":true},{"date":"2023-12-31","value":82.55,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit(616.00K)(2.63M)(1.65M)(4.89M)(6.72M)[{"date":"2020-12-31","value":-61600000,"profit":false},{"date":"2021-12-31","value":-262800000,"profit":false},{"date":"2022-12-31","value":-164700000,"profit":false},{"date":"2023-12-31","value":-489500000,"profit":false},{"date":"2024-12-31","value":-671800000,"profit":false}]
Gross Margin(11.37%)(695.24%)(93.00%)(751.92%)-[{"date":"2020-12-31","value":-11.37,"profit":false},{"date":"2021-12-31","value":-695.24,"profit":false},{"date":"2022-12-31","value":-93,"profit":false},{"date":"2023-12-31","value":-751.92,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses40.35M15.49M18.70M11.99M8.53M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":38.39,"profit":true},{"date":"2022-12-31","value":46.36,"profit":true},{"date":"2023-12-31","value":29.73,"profit":true},{"date":"2024-12-31","value":21.15,"profit":true}]
Operating Income(40.96M)(18.12M)(20.35M)(16.89M)(15.25M)[{"date":"2020-12-31","value":-4096300000,"profit":false},{"date":"2021-12-31","value":-1811600000,"profit":false},{"date":"2022-12-31","value":-2035200000,"profit":false},{"date":"2023-12-31","value":-1688900000,"profit":false},{"date":"2024-12-31","value":-1525200000,"profit":false}]
Total Non-Operating Income/Expense1.18M1.84M79.88M13.20M2.53M[{"date":"2020-12-31","value":1.47,"profit":true},{"date":"2021-12-31","value":2.3,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":16.53,"profit":true},{"date":"2024-12-31","value":3.17,"profit":true}]
Pre-Tax Income(40.38M)(17.15M)59.14M(10.29M)(13.00M)[{"date":"2020-12-31","value":-68.27,"profit":false},{"date":"2021-12-31","value":-28.99,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-17.39,"profit":false},{"date":"2024-12-31","value":-21.99,"profit":false}]
Income Taxes4.00K5.00K13.00K14.85M-[{"date":"2020-12-31","value":0.03,"profit":true},{"date":"2021-12-31","value":0.03,"profit":true},{"date":"2022-12-31","value":0.09,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(40.38M)(17.15M)59.13M(25.13M)-[{"date":"2020-12-31","value":-68.29,"profit":false},{"date":"2021-12-31","value":-29.01,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-42.51,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(40.38M)(35.10M)59.13M(10.29M)(13.00M)[{"date":"2020-12-31","value":-68.29,"profit":false},{"date":"2021-12-31","value":-59.36,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-17.4,"profit":false},{"date":"2024-12-31","value":-21.99,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(40.38M)(35.10M)42.52M(18.40M)(13.00M)[{"date":"2020-12-31","value":-94.98,"profit":false},{"date":"2021-12-31","value":-82.56,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-43.27,"profit":false},{"date":"2024-12-31","value":-30.59,"profit":false}]
EPS (Diluted)(0.48)(0.29)-(2.00)(0.50)[{"date":"2020-12-31","value":-48,"profit":false},{"date":"2021-12-31","value":-29,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-200.01,"profit":false},{"date":"2024-12-31","value":-50.4,"profit":false}]

Talphera Inc. Ratios

Talphera Inc. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

TLPH
Cash Ratio 6.63
Current Ratio 6.83

Talphera Inc. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TLPH
ROA (LTM) -31.46%
ROE (LTM) -86.48%

Talphera Inc. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TLPH
Debt Ratio Lower is generally better. Negative is bad. 0.38
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.62

Talphera Inc. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TLPH
Trailing PE NM
Forward PE NM
P/S (TTM) 1352.84
P/B 1.99
Price/FCF NM
EV/R 600.51
EV/Ebitda 0.11

FAQs

What is Talphera Inc. share price today?

Talphera Inc. (TLPH) share price today is $0.797

Can Indians buy Talphera Inc. shares?

Yes, Indians can buy shares of Talphera Inc. (TLPH) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TLPH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Talphera Inc. be purchased?

Yes, you can purchase fractional shares of Talphera Inc. (TLPH) via the Vested app. You can start investing in Talphera Inc. (TLPH) with a minimum investment of $1.

How to invest in Talphera Inc. shares from India?

You can invest in shares of Talphera Inc. (TLPH) via Vested in three simple steps:

  • Click on Sign Up or Invest in TLPH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Talphera Inc. shares
What is Talphera Inc. 52-week high and low stock price?

The 52-week high price of Talphera Inc. (TLPH) is $1.57. The 52-week low price of Talphera Inc. (TLPH) is $0.38.

What is Talphera Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Talphera Inc. (TLPH) is

What is Talphera Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Talphera Inc. (TLPH) is 1.99

What is Talphera Inc. dividend yield?

The dividend yield of Talphera Inc. (TLPH) is 0.00%

What is the Market Cap of Talphera Inc.?

The market capitalization of Talphera Inc. (TLPH) is $37.86M

What is Talphera Inc.'s stock symbol?

The stock symbol (or ticker) of Talphera Inc. is TLPH

How Can Investors Use Talphera Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of Talphera Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Talphera Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Talphera Inc. shares for Indian investors?

When investing in Talphera Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Talphera Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Talphera Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of Talphera Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Talphera Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top